Chemoinformaics analysis of 4-(1-METHYLPIPERIDIN-4-YL)BENZENE-1,2-DIOL
| Molecular Weight | 207.273 | nRot | 1 |
| Heavy Atom Molecular Weight | 190.137 | nRig | 12 |
| Exact Molecular Weight | 207.126 | nRing | 2 |
| Solubility: LogS | -1.491 | nHRing | 1 |
| Solubility: LogP | 1.171 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 34.0795 |
| nHD | 2 | BPOL | 18.7645 |
| QED | 0.691 |
| Synth | 2.05 |
| Natural Product Likeliness | 0.318 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.972 |
| HIA | 0.017 |
| CACO-2 | -4.593 |
| MDCK | 0.00000811 |
| BBB | 0.98 |
| PPB | 0.342548 |
| VDSS | 1.863 |
| FU | 0.609809 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.829 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.725 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.283 |
| CYP2d6-inh | 0.158 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.311 |
| CL | 18.078 |
| T12 | 0.797 |
| hERG | 0.115 |
| Ames | 0.254 |
| ROA | 0.697 |
| SkinSen | 0.95 |
| Carcinogencity | 0.143 |
| EI | 0.062 |
| Respiratory | 0.928 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.612138 |